FEATURE ARTICLES
Patch adhesion is more than a stickiness test. Let's take a closer look at the FDA's July 2026 final guidance, Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs.
- Developing Your Vapor Phase Hydrogen Peroxide Cycle
- AI In Action: Evaluating Project Assessment
- IT/OT Convergence Could Lighten Biopharma's Automation Burden
- How Peptides Are Expanding The Possibilities Of Drug Discovery
- The 2026 Pharma R&D AI Sourcing Map: Partnerships, Concentration, Inflection
- Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
- What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
PHARMA ONLINE WHITE PAPERS
-
Accelerated API Manufacturing: Combining All Process Development Stages
During early-stage development, utilize the key considerations outlined in this paper to avoid common pitfalls and expedite the transition from molecule to market.
-
Accelerate Lead Times Through Seamless External Collaboration In Quality5/21/2026
As CDMO networks expand, disconnected quality processes create delays and risk. Learn how seamless external collaboration improves visibility, accelerates approvals, and strengthens sponsor–partner relationships—helping teams move faster without compromising compliance.
-
Delivering Critical Therapies With Speed And Safety6/26/2026
Faster approvals depend on treating regulation as part of development, not the finish line. See how early quality planning and strong agency communication can move therapies toward patients sooner.
-
Why Get Cleaning Validation Support From The Cleaner Supplier?6/22/2026
Standardize compliant cleaning by integrating risk-based validation, effective residue detection, and science-based limits to reduce cross-contamination and protect product quality.
-
Accelerating An Innovative High Potency Oncology Therapy To Market5/13/2026
Assimilate how disciplined containment, proactive risk management, and collaboration accelerate oncology programs under tight timelines while protecting quality, safety, and global launch readiness.
-
A Shift Towards Biofluorescent Particle Counters In Manufacturing5/12/2025
Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.
PHARMA ONLINE APP NOTES & CASE STUDIES
NEWSLETTER ARCHIVE
- 11.18.26 -- Is It Time To Rethink Your Protein Expression Strategy?
- 11.18.26 -- OPCU: Preparing Fill-Finish Operations For Scale And Commercial Supply
- 11.18.26 -- What If The Body Could Make Its Own Medicine?
- 11.17.26 -- Advancing Small Molecule Manufacturing
- 11.17.26 -- Turning Data Into Development Confidence
INDUSTRY NEWS
-
Let Your Voice Help Shape Pharma Manufacturing
Pharmaceutical Online hosts live virtual panels with industry experts on important topics and challenges, and we want to know what topics are important to you. Please consider taking a few minutes of your time to tell us what they are.
-
ISPE Announces 2026 FOYA Winners
These awards recognize pharmaceutical and biopharmaceutical manufacturing projects that demonstrate excellence across innovation, operations, supply chain, Pharma 4.0, and social impact.
-
Høeg In, Pazdur Out At The FDA
What an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
EDITORIAL COLLECTIONS
Our curated Editorial Collections bring expert insights together in one place, offering practical perspectives and actionable guidance to help you navigate complex decisions and improve performance.
More Editorial CollectionsSUPPLIER NEWS
-
Inside information: Nanoform Selects Global CDMO Partner For GMP Manufacturing Of Ultra-High-Concentration Biologics11/17/2026
Nanoform Finland Plc (“Nanoform”), the medicine performance-enhancing company, announced today that it has signed an agreement with a CDMO partner for implementation of Nanoform’s biologics technology at one of the Partner’s European facilities for aseptic manufacturing and fill and finish of biological products.
-
Lonza Signs Agreement To Acquire US CDMO Network From Merck KGaA, Darmstadt, Germany, And Significantly Expands Its US Presence11/3/2026
Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced today that it has signed a definitive agreement to acquire five CDMO manufacturing sites in the US from Merck KGaA, Darmstadt, Germany at a total enterprise valuation in the low- to mid-triple-digit millions Swiss francs.
-
Bracco To Build New Injectable Drug Manufacturing Facility In North Carolina11/2/2026
Bracco, a global leader in diagnostic imaging, today announced plans to invest $230 million to establish its first U.S. manufacturing facility for injectable contrast media in Sanford, North Carolina. Expected to create 200 jobs, the investment marks a significant milestone in Bracco's global manufacturing strategy, expanding production capacity and strengthening supply chain resilience in the United States, the company's largest market.
-
Lonza Further Expands Bioconjugation Manufacturing To Support Growing ADC Demand10/29/2026
Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced today the further expansion of its integrated bioconjugation manufacturing offering. Lonza is combining the flexibility of mid-scale bioconjugation manufacturing with its previously announced large-scale bioconjugation expansion in Visp (CH), which will now include three multiproduct suites. Together, these capabilities will offer customers a scalable manufacturing pathway from clinical development through commercial supply for antibody-drug conjugates (ADCs) and other bioconjugates.
-
ROSS Portable High Shear Mixing System10/29/2026

